Dr. Francesca Cossarini
Infectious Disease (Infectious Disease Physician)
- Medicare participating
At a glance
- Years since graduation
- 21
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 33
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Infectious Disease Physician primary
NY license 299356 -
Internal Medicine Physician
NY license 299356 - Student in an Organized Health Care Education/Training Program
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Mount Sinai Hospital New York, NY
- Mount Sinai West New York, NY
Medical groups
- Icahn School of Medicine at Mount Sinai (2,843 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 33
- Services billed
- 92
- Patients’ average age
- 66
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Biktarvy (bictegrav/emtricit/tenofov ala) | 254 |
| Atorvastatin Calcium Other prescribers in New York, NY | 177 |
| Triumeq (abacavir/dolutegravir/lamivudi) | 115 |
| Albuterol Sulfate Hfa (albuterol sulfate) Other prescribers in New York, NY | 79 |
| Lisinopril Other prescribers in New York, NY | 73 |
| Losartan Potassium Other prescribers in New York, NY | 71 |
| Tivicay (dolutegravir sodium) | 59 |
| Gabapentin Other prescribers in New York, NY | 56 |
| Amlodipine Besylate Other prescribers in New York, NY | 52 |
| Vitamin D2 (ergocalciferol (vitamin d2)) Other prescribers in New York, NY | 51 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Industry-funded research
Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $13,784 in research payments for these studies, mostly to the institutions running them.
- A phase 2B multicenter, randomized, open-label study comparing the eff
Viiv Healthcare Company
From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.